<VariationArchive VariationID="1457431" VariationName="NM_000380.4(XPA):c.689dup (p.Arg231fs)" VariationType="Duplication" Accession="VCV001457431" Version="6" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-07-07" DateCreated="2022-03-28" MostRecentSubmission="2024-07-07">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1393372" VariationID="1457431">
      <GeneList>
        <Gene Symbol="XPA" FullName="XPA, DNA damage recognition and repair factor" GeneID="7507" HGNC_ID="HGNC:12814" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>9q22.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="97654398" stop="97697340" display_start="97654398" display_stop="97697340" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="100437190" stop="100459690" display_start="100437190" display_stop="100459690" Strand="-" />
          </Location>
          <OMIM>611153</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000380.4(XPA):c.689dup (p.Arg231fs)</Name>
      <CanonicalSPDI>NC_000009.12:97675571:A:AA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>9q22.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="97675571" stop="97675572" display_start="97675571" display_stop="97675572" variantLength="1" positionVCF="97675571" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="100437853" stop="100437854" display_start="100437853" display_stop="100437854" variantLength="1" positionVCF="100437853" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
      </Location>
      <ProteinChange>R189fs</ProteinChange>
      <ProteinChange>R231fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.100437854dup" Assembly="GRCh37">
            <Expression>NC_000009.11:g.100437854dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.12" sequenceAccession="NC_000009" sequenceVersion="12" change="g.97675572dup" Assembly="GRCh38">
            <Expression>NC_000009.12:g.97675572dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011642.1" sequenceAccession="NG_011642" sequenceVersion="1" change="g.26838dup">
            <Expression>NG_011642.1:g.26838dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000380.4" sequenceAccession="NM_000380" sequenceVersion="4" change="c.689dup" MANESelect="true">
            <Expression>NM_000380.4:c.689dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000371.1" sequenceAccession="NP_000371" sequenceVersion="1" change="p.Arg231fs">
            <Expression>NP_000371.1:p.Arg231fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354975.2" sequenceAccession="NM_001354975" sequenceVersion="2" change="c.563dup">
            <Expression>NM_001354975.2:c.563dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341904.1" sequenceAccession="NP_001341904" sequenceVersion="1" change="p.Arg189fs">
            <Expression>NP_001341904.1:p.Arg189fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_027302.2" sequenceAccession="NR_027302" sequenceVersion="2" change="n.968dup">
            <Expression>NR_027302.2:n.968dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_149091.2" sequenceAccession="NR_149091" sequenceVersion="2" change="n.465dup">
            <Expression>NR_149091.2:n.465dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_149092.2" sequenceAccession="NR_149092" sequenceVersion="2" change="n.631dup">
            <Expression>NR_149092.2:n.631dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_149093.2" sequenceAccession="NR_149093" sequenceVersion="2" change="n.1157dup">
            <Expression>NR_149093.2:n.1157dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_149094.2" sequenceAccession="NR_149094" sequenceVersion="2" change="n.1051dup">
            <Expression>NR_149094.2:n.1051dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_471" sequenceAccession="LRG_471">
            <Expression>LRG_471:g.26838dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000380.4" sequenceAccession="NM_000380" sequenceVersion="4" change="c.689dupT" MANESelect="true">
            <Expression>NM_000380.4:c.689dupT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2131379218" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000380.4(XPA):c.689dup (p.Arg231fs) AND not provided" Accession="RCV001949247" Version="3">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-10-17" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000380.4(XPA):c.689dup (p.Arg231fs) AND Xeroderma pigmentosum" Accession="RCV004526164" Version="2">
        <ClassifiedConditionList TraitSetID="7951">
          <ClassifiedCondition DB="MedGen" ID="C0043346">Xeroderma pigmentosum</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-03-12" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-12" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2022-03-28" MostRecentSubmission="2024-07-07">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">20574439</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31478152</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="7951" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="7021" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Xeroderma pigmentosum</ElementValue>
                <XRef ID="Xeroderma+pigmentosum/7564" DB="Genetic Alliance" />
                <XRef ID="MONDO:0019600" DB="MONDO" />
                <XRef ID="44600005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Xeroderma pigmentosa</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">XP</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Xeroderma pigmentosum (XP) is characterized by: Acute sun sensitivity (severe sunburn with blistering, persistent erythema on minimal sun exposure) with marked freckle-like pigmentation of the face before age two years; Sunlight-induced ocular involvement (photophobia, severe keratitis, atrophy of the skin of the lids, ocular surface neoplasms); Greatly increased risk of sunlight-induced cutaneous neoplasms (basal cell carcinoma, squamous cell carcinoma, melanoma) within the first decade of life. Approximately 25% of affected individuals have neurologic manifestations (acquired microcephaly, diminished or absent deep tendon stretch reflexes, progressive sensorineural hearing loss, progressive cognitive impairment, and ataxia). The most common causes of death are skin cancer, neurologic degeneration, and internal cancer. The median age at death in persons with XP with neurodegeneration (29 years) was found to be younger than that in persons with XP without neurodegeneration (37 years).</Attribute>
                <XRef ID="NBK1397" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7910" />
                <XRef ID="7910" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301571</ID>
                <ID Source="BookShelf">NBK1397</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Skin Cancer">
                <ID Source="PubMed">26389333</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <XRef ID="910" DB="Orphanet" />
              <XRef ID="C0043346" DB="MedGen" />
              <XRef ID="MONDO:0019600" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4260072" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="4881212|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002247208" DateUpdated="2024-02-14" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-10-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">20574439</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31478152</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20574439</ID>
          </Citation>
          <Comment>This premature translational stop signal has been observed in individual(s) with xeroderma pigmentosum (PMID: 20574439). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Arg231Lysfs*15) in the XPA gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 43 amino acid(s) of the XPA protein. This variant is also known as 690insT. For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the XPA protein in which other variant(s) (p.Arg258Tyrfs*5) have been determined to be pathogenic (PMID: 31478152). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. Studies have shown that this premature translational stop signal does not significantly alter or has an unclear effect on XPA gene expression (PMID: 20574439). ClinVar contains an entry for this variant (Variation ID: 1457431).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="XPA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000009.11:g.100437853_100437854insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9756568" SubmissionDate="2024-06-29" DateLastUpdated="2024-07-07" DateCreated="2024-05-07">
        <ClinVarSubmissionID localKey="NM_000380.4:c.689dupT|MedGen:C0043346" />
        <ClinVarAccession Accession="SCV005039470" DateUpdated="2024-07-07" DateCreated="2024-05-07" Type="SCV" Version="2" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">20574439</ID>
          </Citation>
          <Comment>Variant summary: XPA c.689dupT (p.Arg231LysfsX15) results in a premature termination codon, predicted to cause a truncation of the encoded protein, though it is not expected to result in nonsense mediated decay. The variant was absent in 251060 control chromosomes (gnomAD). c.689dupT has been reported in the literature in an individual affected with a milder form of Xeroderma Pigmentosum who was compound heterozygous with a pathogenic variant (Takahashi_2010). The patient expressed reduced levels of XPA mRNA and a truncated protein. The following publication has been ascertained in the context of this evaluation (PMID: 20574439). ClinVar contains an entry for this variant (Variation ID: 1457431). Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="XPA" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000380.4:c.689dupT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0043346" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>clinvar-submission.2024-03.anno.csv</SubmissionName>
          <SubmissionName>clinvar-submission.2024-03.csv</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9756568" TraitType="Disease" MappingType="XRef" MappingValue="C0043346" MappingRef="MedGen">
        <MedGen CUI="C0043346" Name="Xeroderma pigmentosum" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4260072" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

